Vancomycin and Antimicrobial susceptibility test resistant - a phase IV clinical study of FDA data

Summary:

Antimicrobial susceptibility test resistant is reported as a side effect among people who take Vancomycin (vancomycin), especially for people who are male, 2-9 old, also take Daptomycin, and have Bacteraemia.

The phase IV clinical study analyzes which people have Antimicrobial susceptibility test resistant when taking Vancomycin. It is created by eHealthMe based on reports of 17,160 people who have side effects when taking Vancomycin from the FDA, and is updated regularly.

What is Vancomycin?

Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.

What is Antimicrobial susceptibility test resistant?

Antimicrobial susceptibility test resistant is found to be associated with 26 drugs and 137 conditions by eHealthMe. Check the latest studies of Antimicrobial susceptibility test resistant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

17,160 people reported to have side effects when taking Vancomycin.
Among them, 79 people (0.46%) have Antimicrobial susceptibility test resistant.

Could Vancomycin cause Antimicrobial susceptibility test resistant?

Among these 79 people:

What is the gender of people who have Antimicrobial susceptibility test resistant when taking Vancomycin? *

  • female: 0.0 %
  • male: 100 %

What is the age of people who have Antimicrobial susceptibility test resistant when taking Vancomycin? *

  • 0-1: 0.0 %
  • 2-9: 97.4 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 2.6 %

What are other drugs people take besides Vancomycin? *

  1. Daptomycin: 53 people, 67.09%
  2. Lansoprazole: 52 people, 65.82%
  3. Dutasteride: 52 people, 65.82%
  4. Tramadol: 32 people, 40.51%
  5. Alfuzosin Hydrochloride: 31 people, 39.24%
  6. Tramadol Hydrochloride: 30 people, 37.97%
  7. Linezolid: 29 people, 36.71%
  8. Bisoprolol Fumarate: 18 people, 22.78%
  9. Cubicin: 3 people, 3.80%
  10. Ceftriaxone: 2 people, 2.53%

What are other side effects people have besides Antimicrobial susceptibility test resistant? *

  1. Lower Respiratory Tract Infection: 76 people, 96.20%
  2. Malaise (a feeling of general discomfort or uneasiness): 65 people, 82.28%
  3. Therapeutic Response Delayed (late preventive response): 61 people, 77.22%
  4. Drug Ineffective: 4 people, 5.06%
  5. Drug Resistance (reduction in effectiveness of a drug): 2 people, 2.53%
  6. Staphylococcal Bacteraemia (a bacterial infection of blood): 1 person, 1.27%
  7. Prosthetic Valve Endocarditis (endovascular, microbial infection occurring on parts of a valve prosthesis or on reconstructed): 1 person, 1.27%
  8. Mediastinal Abscess (rare presentation of infections involving the mediastinum): 1 person, 1.27%
  9. Implant Site Inflammation: 1 person, 1.27%
  10. Endocarditis (inflammation in heart muscle): 1 person, 1.27%

What are the existing conditions these people have? *

  1. Bacteraemia (presence of bacteria in the blood): 73 people, 92.41%
  2. Device Related Infection: 71 people, 89.87%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 36 people, 45.57%
  4. Lower Respiratory Tract Infection: 9 people, 11.39%
  5. Endocarditis Enterococcal (an inflammation of the inner layer of the heart by lactic acid bacteria of the phylum firmicutes): 2 people, 2.53%
  6. Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 1.27%
  7. Staphylococcal Bacteraemia (a bacterial infection of blood): 1 person, 1.27%
  8. Graft Infection (infection of graft site): 1 person, 1.27%

* Approximation only. Some reports may have incomplete information.

Do you take Vancomycin and have Antimicrobial susceptibility test resistant?

- Check whether Antimicrobial susceptibility test resistant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vancomycin:

Antimicrobial susceptibility test resistant treatments and more:

How severe was Antimicrobial susceptibility test resistant and when was it recovered:

Expand to all the drugs that have ingredients of vancomycin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vancomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Antimicrobial susceptibility test resistant:

Browse all the conditions that are associated with Antimicrobial susceptibility test resistant:


How the study uses the data?

The study uses data from the FDA. It is based on vancomycin (the active ingredients of Vancomycin) and Vancomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: